Literature DB >> 22001844

Expression of soluble and functional full-length human matrix metalloproteinase-2 in Escherichia coli.

Andrezza N Gonçalves1, Cesar A Meschiari, William G Stetler-Stevenson, M Cristina Nonato, Cleidson P Alves, Enilza M Espreafico, Raquel F Gerlach.   

Abstract

Characterization of the matrix metalloproteinase-2 (MMP-2) substrates and understanding of its function remain difficult because up to date preparations containing minor amounts of other eukaryotic proteins that are co-purified with MMP-2 are still used. In this work, the expression of a soluble and functional full-length recombinant human MMP-2 (rhMMP-2) in the cytoplasm of Escherichia coli is reported, and the purification of this metalloproteinase is described. Culture of this bacterium at 18°C culminated in maintenance of the soluble and functional rhMMP-2 in the soluble fraction of the E. coli lysate and its purification by affinity with gelatin-sepharose yielded approximately 0.12mg/L of medium. Western Blotting and zymographic analysis revealed that the most abundant form was the 72-kDa MMP-2, but some gelatinolytic bands corresponding to proteins with lower molecular weight were also detected. The obtained rhMMP-2 was demonstrated to be functional in a gelatinolytic fluorimetric assay, suggesting that the purified rhMMP-2 was correctly folded. The method described here involves fewer steps, is less expensive, and is less prone to contamination with other proteinases and MMP inhibitors as compared to expression of rhMMP-2 in eukaryotic tissue culture. This protocol will facilitate the use of the full-length rhMMP-2 expressed in bacteria and will certainly help researchers to acquire new knowledge about the substrates and biological activities of this important proteinase.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001844      PMCID: PMC3462441          DOI: 10.1016/j.jbiotec.2011.09.030

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  30 in total

Review 1.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.

Authors:  Robert Visse; Hideaki Nagase
Journal:  Circ Res       Date:  2003-05-02       Impact factor: 17.367

2.  Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor.

Authors:  C Fernandez-Patron; M W Radomski; S T Davidge
Journal:  Circ Res       Date:  1999-11-12       Impact factor: 17.367

3.  Fragmentation of fibronectin by inherent autolytic and matrix metalloproteinase activities.

Authors:  Bjorn Steffensen; Zhihua Chen; Sanjay Pal; Margarita Mikhailova; Jianrong Su; Yao Wang; Xiaoping Xu
Journal:  Matrix Biol       Date:  2010-10-13       Impact factor: 11.583

4.  Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway.

Authors:  C J Morrison; G S Butler; H F Bigg; C R Roberts; P D Soloway; C M Overall
Journal:  J Biol Chem       Date:  2001-10-02       Impact factor: 5.157

5.  Isolation and characterization of a 70-kDa metalloprotease (gelatinase) that is elevated in Rous sarcoma virus-transformed chicken embryo fibroblasts.

Authors:  J M Chen; R T Aimes; G R Ward; G L Youngleib; J P Quigley
Journal:  J Biol Chem       Date:  1991-03-15       Impact factor: 5.157

6.  Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.

Authors:  T Morodomi; Y Ogata; Y Sasaguri; M Morimatsu; H Nagase
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

7.  Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro.

Authors:  Jennifer A Kwan; Costas J Schulze; Wenjie Wang; Hernando Leon; Meltem Sariahmetoglu; Miranda Sung; Jolanta Sawicka; David E Sims; Grzegorz Sawicki; Richard Schulz
Journal:  FASEB J       Date:  2004-02-06       Impact factor: 5.191

8.  Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions.

Authors:  R Fridman; T R Fuerst; R E Bird; M Hoyhtya; M Oelkuct; S Kraus; D Komarek; L A Liotta; M L Berman; W G Stetler-Stevenson
Journal:  J Biol Chem       Date:  1992-08-05       Impact factor: 5.157

9.  Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction.

Authors:  Cindy Qun Gao; Grzegorz Sawicki; Wilma L Suarez-Pinzon; Tamás Csont; Mieczyslaw Wozniak; Péter Ferdinandy; Richard Schulz
Journal:  Cardiovasc Res       Date:  2003-02       Impact factor: 10.787

10.  Purification and characterization of catalytic domains of gelatinase A with or without fibronectin insert for high-throughput inhibitor screening.

Authors:  Donghang Cheng; Qiang Shen; Fajun Nan; Zhen Qian; Qi-Zhuang Ye
Journal:  Protein Expr Purif       Date:  2003-01       Impact factor: 1.650

View more
  6 in total

1.  Matrix-assisted refolding, purification and activity assessment using a 'form invariant' assay for matrix metalloproteinase 2 (MMP2).

Authors:  Krishna Kumar Singh; Ruchi Jain; Harini Ramanan; Deepak Kumar Saini
Journal:  Mol Biotechnol       Date:  2014-12       Impact factor: 2.695

2.  Modification in media composition to obtain secretory production of STxB-based vaccines using Escherichia coli.

Authors:  Mohammad Sadraeian; Mohammad Bagher Ghoshoon; Milad Mohkam; Zeinab Karimi; Sara Rasoul-Amini; Younes Ghasemi
Journal:  Virol Sin       Date:  2013-01-17       Impact factor: 4.327

3.  Matrix metalloproteinase-2-induced epidermal growth factor receptor transactivation impairs redox balance in vascular smooth muscle cells and facilitates vascular contraction.

Authors:  Alejandro F Prado; Laena Pernomian; Aline Azevedo; Rute A P Costa; Elen Rizzi; Junia Ramos; Adriana F Paes Leme; Lusiane M Bendhack; Jose E Tanus-Santos; Raquel F Gerlach
Journal:  Redox Biol       Date:  2018-07-09       Impact factor: 11.799

4.  MT1-MMP activatable fluorogenic probes with enhanced specificity via high-affinity peptide conjugation for tumor imaging.

Authors:  Xiuru Ji; Shuping Xie; Yan Jiao; Xiaojuan Zhang; Duxin Sun; Victor C Yang; Mei Wang; Huining He; Lu Sun
Journal:  Biomater Sci       Date:  2020-03-18       Impact factor: 6.843

5.  Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension.

Authors:  Danielle A Guimarães; Elen Rizzi; Carla S Ceron; Alisson Martins-Oliveira; Raquel F Gerlach; Sruti Shiva; Jose E Tanus-Santos
Journal:  Redox Biol       Date:  2015-08-31       Impact factor: 11.799

6.  Elevated serum matrix metalloprotease (MMP-2) as a candidate biomarker for stable COPD.

Authors:  Durga Mahor; Vandana Kumari; Kapil Vashisht; Ruma Galgalekar; Ravindra M Samarth; Pradyumna K Mishra; Nalok Banerjee; Rajnikant Dixit; Rohit Saluja; Sajal De; Kailash C Pandey
Journal:  BMC Pulm Med       Date:  2020-11-16       Impact factor: 3.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.